American Cell Technology Revenue and Competitors
Estimated Revenue & Valuation
- American Cell Technology's estimated annual revenue is currently $1.7M per year.
- American Cell Technology's estimated revenue per employee is $94,722
Employee Data
- American Cell Technology has 18 Employees.
- American Cell Technology grew their employee count by 100% last year.
American Cell Technology's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Head Quality Control | Reveal Email/Phone |
4 | Operations Specialist and Account Manager | Reveal Email/Phone |
5 | Laboratory Technician | Reveal Email/Phone |
6 | Lead Manufacturing Associate | Reveal Email/Phone |
7 | System Analyst | Reveal Email/Phone |
8 | Laboratory Technician | Reveal Email/Phone |
9 | Laboratory Technician | Reveal Email/Phone |
10 | Laboratory Technician | Reveal Email/Phone |
American Cell Technology Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 93 | 15% | N/A | N/A |
#2 | N/A | 10 | 0% | N/A | N/A |
#3 | $1.1M | 6 | 0% | N/A | N/A |
#4 | $3.7M | 24 | 20% | N/A | N/A |
#5 | $4.3M | 25 | 9% | N/A | N/A |
#6 | $2.5M | 16 | N/A | N/A | N/A |
#7 | $0.8M | 4 | 0% | N/A | N/A |
#8 | $1.1M | 6 | 0% | N/A | N/A |
#9 | $2.5M | 14 | 8% | N/A | N/A |
#10 | $1.4M | 3 | -57% | N/A | N/A |
What Is American Cell Technology?
American Cell Technology provides leading edge personal stem cell banking services to collect, process, grow and store adult and newborn autologous Mesenchymal Stem Cells (your own MSCs) for potential future medical or regenerative use as determined by you and your personal physician
keywords:N/AN/A
Total Funding
18
Number of Employees
$1.7M
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.9M | 18 | -18% | N/A |
#2 | $2.4M | 20 | -13% | N/A |
#3 | $5M | 20 | -23% | N/A |
#4 | N/A | 20 | -13% | N/A |
#5 | $3.9M | 20 | -9% | N/A |